Navigation Links
Genaera Presents Promising Preclinical Data for Trodusquemine (MSI-1436) at Keystone Symposia
Date:1/22/2009

lood sugar. Initial clinical studies of trodusquemine in obese and overweight subjects has provided early indicators of weight loss and improved glucose control. These results confirm previous work in animal models which demonstrated significant weight loss without metabolic rebound, which often limits sustained weight loss during caloric restriction. In addition, trodusquemine has shown the ability to reverse co-morbidities associated with obesity such as abnormal glucose metabolism and cholesterol elevation.

About Genaera

Genaera Corporation is developing trodusquemine (MSI-1436), for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in asthma. For further information, please see our website at www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to the risks and uncertainties discussed in Genaera's filings with the U.S. Securities and Exchange Commission, all of which are available from the Commission in its EDGAR database at www.sec.gov as
'/>"/>

SOURCE Genaera Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics
2. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
3. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
4. Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
5. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
6. Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
7. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
8. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
9. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
10. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... Calif. , July 22, 2014  Based ... imaging (MRI) market, Frost & Sullivan recognizes Siemens ... Product Leadership. Siemens Healthcare,s FREEZEit solution, which employs ... need for robust and motion-insensitive imaging. The solution,s ... the evolution of body MRI imaging in the ...
(Date:7/22/2014)...  PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, ... healthcare products, announced today that the company is ... "We are pleased to sponsor Operation Troop ... Chairman of PuraMed BioScience. "Research shows that many ... migraines much more frequently than the general population. ...
(Date:7/22/2014)... /PRNewswire-iReach/ -- Reproductive Medicine Associates of New York ... a nationally and internationally-recognized leader in providing exceptional quality ... pleased to announce a new collaboration with EMD Serono ... recognize the sacrifices made by veterans and their families ... will allow qualifying veterans and the spouses of veterans ...
Breaking Medicine Technology:Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 2Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 3Frost & Sullivan Recognizes Siemens Healthcare with the Product Leadership Award for Innovative Techniques in Abdominal Imaging 4PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 2Reproductive Medicine Associates of New York Collaborates with EMD Serono to Offer Treatment Assistance to Eligible Veterans and their Spouses 3
... , , New collaborative research program to study effects ... Dec. 30 A new research program called the Medication ... to study the effects of prescription medications used during pregnancy. ... Drug Administration and researchers at the HMO Research Network Center ...
... , BOSTON, Dec. 30 Solos Endoscopy, Inc. (Pink ... to a prosperous 2010, following a solid year in 2009, due ... the closing months of 2009, Solos Endoscopy, Inc. has taken the ... of surgical endoscopy instruments. This will allow the MammoView(TM) line to ...
Cached Medicine Technology:FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 2FDA, Health Organizations to Study Safety of Medications Taken During Pregnancy 3Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:7/22/2014)... American Society of Hematology (ASH) will honor Michael DeBaun, ... Robert P. Hebbel, MD, of the University of Minnesota ... Prize for their significant research advances in the area ... named for the late Ernest Beutler, MD, a past ... years, is a two-part lectureship that recognizes major translational ...
(Date:7/22/2014)... Marc, Ph.D., director of research at the University of ... by the International Society of Eye Research (ISER) as ... 2014 Paul Kayser International Award in Retina Research., The ... has made a significant contribution to the understanding of ... this week at the ISER Biennial Meeting in San ...
(Date:7/22/2014)... D.C. (PRWEB) July 22, 2014 ... “Ensuring Seniors Access to Local Pharmacies Act of ... Medicare Part D would undermine the availability of ... spending by $21 billion over the next 10 ... Company released by the Pharmaceutical Care Management Association ...
(Date:7/22/2014)... may share certain pathogenic mechanisms with cancer, according to ... Linda Kusner, Ph.D. , published in PLOS ... work shows that the very same inhibitors of apoptosis, ... cells that produce autoimmune diseases. Henry Kaminski, M.D. ... GW School of Medicine and Health Sciences (SMHS), as ...
(Date:7/22/2014)... July 22, 2014 The Beryl Institute ... third annual Institute Scholar Program. These offerings reinforce the ... patient experience in healthcare and the need for rigorous ... grant and scholar programs are intended to ... Value of focusing on the patient experience before, ...
Breaking Medicine News(10 mins):Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:University of Utah researcher Robert Marc receives Paul Kayser International Award 2Health News:PCMA: New Study Finds H.R. 4577 to Cost $21 Billion Over 10 Years 2Health News:New research finds pathogenic connection between autoimmune disorders and cancer 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3
... they took the advice of the government in refusing to ... three children. Swindon NHS chiefs said that the denial of ... advice from their superiors.// ,Herceptin is not licensed ... are suing the NHS for its failure to provide the ...
... the National Heart, Lung, and Blood Institute (NHLBI), has ... high blood pressure., ,The education would be given ... who have been trained to educate other physicians in ... help doctors and patients prevent and better treat high ...
... disease), Russia has put a stop and a aban on ... animal feed from the Argentine province of Corrientes. The action ... by the the Agriculture Ministry of Russia. ,The ... health body), about an outbreak of the disease in cattle ...
... vaccine in the US is expected to enhance the supply ... preparation. Currently, the Australian manufacturer, //CSL, is selling the flu ... to a Swiss based Berna Biotech enables distribution of the ... have expressed hope over initiation of clinical trials in the ...
... immediately after birth may be the best indicator of subsequent ... fatigues two weeks after the birth of their child were ... mothers are tired right after having a baby - it ... and heal from the physical and mental stressors of childbirth," ...
... University Medical Center have found that the lethal impact ... anticipated. Researchers from the Mailman School of Public Health ... study, which// appears in the February issue of Diabetes ... and treat periodontal disease should be considered a standard ...
Cached Medicine News:Health News:Extension Education for Blood Pressure advice! 2Health News:Persistent Fatigue Could Be An Early Indicator Of Postpartum Depression 2Health News:Gum Disease Affects Diabetic Children Earlier Than Anticipated 2
Based on the trusted Schaltenbrand-Wahren Atlas for Stereotaxy of the human brain, Atlasplan Software provides anatomical detail of the basal ganglia region of the brain and can help confirm target a...
... the most advanced image-guided platforms available ... of an expandable platform. In addition ... supports new applications in electromagnetics (EM). ... well as the ability to track ...
... The Mayfield 2000 series radiolucent headrest system ... intraoperative digital subtraction angiography. This system is ... skull clamp and the Mayfield radiolucent base ... designed for patient positioning in the prone ...
Bunnel hand drill with Jacobs chuck, chuck size 4 mm....
Medicine Products: